Molecular characterization of clinical response and relapse in patients with IDH1m ND-AML treated with Ivo+AZA in the aGILE study (2022)
- Authors:
- Döhner, Hartmut
- Marchione, Dylan M.
- Choe, Sung
- Montesinos, Pau
- Recher, Christian
- Vives, Susana
- Zarzycka, Ewa
- Wang, Jianxiang
- Cerchione, Claudio
- Heuser, Michael
- Calado, Rodrigo Tocantins
- Schuh, Andre C.
- Yeh, Su-Peng
- De La Fuente, Adolfo
- Hui, Jianan
- Patel, Prapti
- Gianolio, Diego
- Daigle, Scott R.
- DiNardo, Courtney D.
- Botton, Stephane de
- Autor USP: RODRIGUES, RODRIGO DO TOCANTINS CALADO DE SALOMA - FMRP
- Unidade: FMRP
- DOI: 10.1182/blood-2022-159473
- Assunto: MOLÉCULA
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: ASH Annual Meeting and Exposition
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
DÖHNER, Hartmut et al. Molecular characterization of clinical response and relapse in patients with IDH1m ND-AML treated with Ivo+AZA in the aGILE study. Blood. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2022-159473. Acesso em: 21 fev. 2026. , 2022 -
APA
Döhner, H., Marchione, D. M., Choe, S., Montesinos, P., Recher, C., Vives, S., et al. (2022). Molecular characterization of clinical response and relapse in patients with IDH1m ND-AML treated with Ivo+AZA in the aGILE study. Blood. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2022-159473 -
NLM
Döhner H, Marchione DM, Choe S, Montesinos P, Recher C, Vives S, Zarzycka E, Wang J, Cerchione C, Heuser M, Calado RT, Schuh AC, Yeh S-P, De La Fuente A, Hui J, Patel P, Gianolio D, Daigle SR, DiNardo CD, Botton S de. Molecular characterization of clinical response and relapse in patients with IDH1m ND-AML treated with Ivo+AZA in the aGILE study [Internet]. Blood. 2022 ; 140( suppl. 1): 539-542.[citado 2026 fev. 21 ] Available from: https://doi.org/10.1182/blood-2022-159473 -
Vancouver
Döhner H, Marchione DM, Choe S, Montesinos P, Recher C, Vives S, Zarzycka E, Wang J, Cerchione C, Heuser M, Calado RT, Schuh AC, Yeh S-P, De La Fuente A, Hui J, Patel P, Gianolio D, Daigle SR, DiNardo CD, Botton S de. Molecular characterization of clinical response and relapse in patients with IDH1m ND-AML treated with Ivo+AZA in the aGILE study [Internet]. Blood. 2022 ; 140( suppl. 1): 539-542.[citado 2026 fev. 21 ] Available from: https://doi.org/10.1182/blood-2022-159473 - Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs
- Cell senescence and malignant transformation in the inherited bone marrow failure syndromes: overlapping pathophysiology with therapeutic implications
- Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia
- Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia
- Telomere shortening in hepatocyte proliferation and predisposition to alcohol-induced steatosis
- Telomerase enzyme deficiency promotes metabolic dysfunction in murine hepatocytes upon dietary stress
- Telomere dynamics in iPS cells derived from human patients with telomerase mutations
- Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia
- Células reprogramadas. [Depoimento a Hérika Dias e Luis Ribeiro]
- A mutation in the CCAAT box of the TERC promoter region causes telomere disease
Informações sobre o DOI: 10.1182/blood-2022-159473 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003271021.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
